HQH ETF

Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing 10 of 0 holdingsTop 10 Weight: 38.59%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1GILDGilead Sciences Inc6.44%--••••••••••••••••••••••
2AMGNAmgen Inc5.97%--••••••••••••••••••••••
3REGNRegeneron Pharmaceuticals Inc5.91%--••••••••••••••••••••••
4VRTXVertex Pharmaceuticals Inc3.96%--••••••••••••••••••••••
5LLYEli Lilly & Co3.57%--••••••••••••••••••••••
6BMRNBioMarin Pharmaceutical Inc2.92%--••••••••••••••••••••••
7ALNYAlnylam Pharmaceuticals Inc2.77%--••••••••••••••••••••••
8UNHUnitedHealth Group Inc2.77%--••••••••••••••••••••••
9GVMXXState Street Global Advisors2.23%--••••••••••••••••••••••
10ABTAbbott Laboratories2.05%--••••••••••••••••••••••
Want to see all 0 holdings?View All HoldingsPRO

HQH ETF Top Holdings

HQH holdings top 10 positions. The top 10 holdings account for 38.6% of the fund, led by Gilead Sciences Inc at 6.4%, Amgen Inc at 6.0%, Regeneron Pharmaceuticals Inc at 5.9%.

HQH portfolio concentration is moderate, with the top 10 representing 38.6% of total assets. The largest sector exposure is Unknown at 91.6%.

HQH sector allocation provides a detailed breakdown. HQH overlap tool shows how holdings compare to other funds in your portfolio.

Showing 10 of 102 holdingsTop 10 Weight: 38.59%
#TickerNameIndustryWeightAllocation
1GILDGilead Sciences IncUnknown6.44%
2AMGNAmgen IncUnknown5.97%
3REGNRegeneron Pharmaceuticals IncUnknown5.91%
4VRTXVertex Pharmaceuticals IncUnknown3.96%
5LLYEli Lilly & CoUnknown3.57%
6BMRNBioMarin Pharmaceutical IncUnknown2.92%
7ALNYAlnylam Pharmaceuticals IncUnknown2.77%
8UNHUnitedHealth Group IncUnknown2.77%
9GVMXXState Street Global AdvisorsUnknown2.23%
10ABTAbbott LaboratoriesUnknown2.05%
Want to see all 102 holdings?

Holdings Distribution

Loading chart...